annamycin has been researched along with Carcinoma, Small Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andreeff, M; Doyle, LA; Ling, YH; Neamati, N; Perez-Soler, R; Priebe, W; Schneider, E; Zou, Y | 1 |
1 other study(ies) available for annamycin and Carcinoma, Small Cell
Article | Year |
---|---|
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
Topics: Antibiotics, Antineoplastic; ATP-Binding Cassette Transporters; Blotting, Western; Breast Neoplasms; Carcinoma, Small Cell; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Tumor Cells, Cultured | 1997 |